RNA interference as a novel treatment strategy for chronic hepatitis B infectionReview Published on 2022-07-012023-06-11 Journal: Clinical and molecular hepatology [Category] B형 간염, Fulltext, [키워드] Anti-sense oligonucleotide Hepatitis B surface antigens Hepatitis B virus Messenger RNA Small-interfering RNA [DOI] 10.3350/cmh.2022.0012 PMC 바로가기 [Article Type] Review
Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients간 이식 환자에서 메신저 RNA-1273 백신(모더나)에 대한 항체 반응Article Published on 2022-07-012022-09-12 Journal: Hepatology communications [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Administered anti-S anti-S IgG antibody cause clinical coronavirus coronavirus disease COVID-19 COVID-19 infection develop dose evaluated examined Factor first vaccination Follow-up General population Hepatitis IgG Immunoglobulin Immunological response immunosuppressive include interquartile range laboratory data liver Liver transplantation Logistic regression LTR LTRs median median age men Messenger RNA Moderna MOST Most patient mRNA mRNA-1273 vaccine mRNA-based vaccine Odds ratio Patient positive predict receiving recipient recipients regimen response RNA-1273 SARS-CoV-2 Serologic response shown tested the spike protein the vaccine university Vaccine vaccine dose [DOI] 10.1002/hep4.1937 PMC 바로가기 [Article Type] Article
Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort StudyArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] COVID19(2023년), SARS, 진단, [키워드] anti-SARS-CoV-2 IgG Antibody Response Antibody titer cofactor cohort study COVID-19 vaccination COVID-19 vaccine dosage dose evaluated Follow-up group groups healthy controls IgG level immune response Immunoglobulin kidney transplant kinetics of antibody median time Messenger RNA no significant difference Pfizer-BioNTech receiving recipient recipients retrospective SARS-CoV-2 second second dose second vaccination Serologic response significantly lower single-center the SARS-CoV-2 to define Transplant treated Vaccine [DOI] 10.1016/j.transproceed.2022.05.002 PMC 바로가기
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccinationCOVID-19 및 COVID-19 백신 접종 후의 혈전증 및 혈소판 감소증Review Published on 2022-07-012022-09-11 Journal: Trends in cardiovascular medicine [Category] COVID19(2023년), SARS, 치료기술, [키워드] ACE2 activate Activation acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive immune system Adenovirus Adenovirus-vectored vaccine administration aggregation angiotensin angiotensin converting enzyme angiotensin converting enzyme 2 Antibody detection Antiplatelet factor cause Coagulation Coagulopathy condition coronavirus coronavirus disease COVID-19 COVID-19 vaccination Critical detect diagnosing Diagnosis Disease progression disease severity dysregulation effective ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay event false-positive rate false-positive rates hemophagocytic lymphohistiocytosis hemophagocytic syndrome immune Immune thrombocytopenic purpura Inflammation initial Interaction lupus erythematosus Messenger RNA mitigate occur optical optical density Pathogenesis PF4 Platelet platelet aggregation Platelets positive progression purpura SARS-CoV-2 serious complication severe acute respiratory syndrome Coronavirus Side effects Spike protein syndrome systemic lupus erythematosus the disease the patient thrombocytopenia thrombocytopenic purpura Thromboembolism thrombosis thrombotic Thrombotic thrombocytopenia Thrombotic thrombocytopenic purpura vaccination Vaccine Vaccines vectored vaccine [DOI] 10.1016/j.tcm.2022.02.008 PMC 바로가기 [Article Type] Review
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSARS-CoV-2 mRNA 백신 접종 후 6개월 후 체액성 면역 반응의 현저한 감소 특성: 체계적인 검토Review Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-Spike IgG antibody Antibody Response Antibody titer Antibody titers appearance article binding domain BNT161b2 BNT162b2 booster Breakthrough infection breakthrough infections calculated characterization Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mRNA Vaccination determine Effect Efficacy Evidence exhibited Factor finding highlight humoral humoral immune response Humoral immunity Humoral response IgG Immunoglobulin Immunoglobulin G independent independent of Kinetics Longitudinal data Messenger RNA Moderna mRNA mRNA 1273 mRNA BNT162b2 mRNA vaccination mRNA-1273 Participants peak levels Pfizer-BioNTech postvaccination presence of comorbidities reached reported respiratory second dose serostatus Serum level serum levels severe acute respiratory syndrome Coronavirus Sex systematic review Vaccination strategy Vaccine Vaccines variant waning immunity was performed [DOI] 10.1002/jmv.27688 PMC 바로가기 [Article Type] Review
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccineB 세포 림프종 환자에서 COVID-19 mRNA 백신을 여러 번 접종한 후 SARS-CoV-2 및 Omicron 변이체에 대한 T 세포 반응Case Reports Published on 2022-07-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Antibody Response B cell B cells CD4 CD8 COVID-19 COVID-19 infections develop disease severity dose expected healthy subject healthy subjects Hematologic malignancy hematologic neoplasms humoral Immune escape immune system immunology Immunosuppression implication initial Lymphocytes lymphoma Messenger RNA mRNA mRNA vaccine multiple dose Neoplasms omicron Patient Patients with cancer protective immunity response SARS-CoV-2 SARS-CoV-2 virus T cell T cell response T cells T-lymphocytes the patient the SARS-CoV-2 virus the vaccine vaccination Vaccination strategy Vaccine Vaccines variant Viral Viral transmission while [DOI] 10.1136/jitc-2022-004953 PMC 바로가기 [Article Type] Case Reports
Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations3 BNT162b2 메신저 RNA 코로나바이러스 질병 2019 예방접종에 대한 공통 가변 면역결핍증 환자 14명의 특이적 항체 반응Article Published on 2022-07-012022-09-12 Journal: Annals of allergy, asthma & immunology : official [Category] MERS, 진단, [키워드] Antibody Response BNT162b2 coronavirus disease immunodeficiency Messenger RNA Patient Specific vaccination [DOI] 10.1016/j.anai.2022.03.035 PMC 바로가기 [Article Type] Article
COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough InfectionsArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] 진단, [키워드] adenoviral vector vaccine Allograft allograft dysfunction Analysis anticoagulation body mass index booster dose Breakthrough infection Chest computed tomography chronic respiratory Clinical efficacy Complete Complication composite endpoint COVID-19 COVID-19 vaccine diagnosed with COVID-19 dose favorable effect group Hospitalization less likelihood lung lung transplant male median age Messenger RNA mRNA multivariate logistic regression parenchymal Patient patients proportion protective effect pulmonary Restrictive lung disease significantly lower significantly more study group survival therapeutic Transplant vaccination worsening respiratory failure [DOI] 10.1016/j.transproceed.2022.05.030 PMC 바로가기
Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?Short communication Published on 2022-07-012022-10-05 Journal: Journal of cardiac failure [Category] 진단, [키워드] age arrhythmia children Cleveland clinic clinician coronavirus disease COVID-19 COVID-19 pandemic COVID-19 vaccination dose Electronic health records Follow-up highlighting history Hospitalized magnetic resonance imaging Messenger RNA mRNA mRNA COVID-19 vaccine myocarditis Myocarditis history Numerous occur Patient receiving reported Result resulting risk second dose Support vaccination vaccine safety white [DOI] 10.1016/j.cardfail.2022.06.011 [Article Type] Short communication
Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth임신 3기 전령 RNA COVID-19 부스터 백신 접종 시 산모 및 신생아 SARS-CoV-2 면역글로불린 G 항체 수준 급증Article Published on 2022-07-012022-09-12 Journal: European journal of obstetrics, gynecology, and re [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval Administered administration Admission analyzed antibodies antibody Antibody titers Blood BNT162b2 BNT162b2 mRNA body mass index booster booster dose booster vaccination Booster vaccine Characteristics contrary correlation COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine dropped evaluate IgG Immunoglobulin increase in Messenger RNA mRNA multivariable analysis Neonatal Newborn pandemic Pfizer/BioNTech Placenta positive correlation Pregnancy pregnant women prospective cohort study reflected response SARS-CoV-2 SARS-CoV-2 IgG antibody Side effect Standard deviation Support systemic side effect Third trimester. umbilical vaccination Vaccine vaccine dose were measured women [DOI] 10.1016/j.ejogrb.2022.05.029 PMC 바로가기 [Article Type] Article